bioSyntagma

Bio Syntagma

Biotechnology, 1878 E Watson Dr, Phoenix, Arizona, 85283, United States, 1-10 Employees

biosyntagma.com

  • facebook
  • LinkedIn

phone no Phone Number: +18*********

Who is BIOSYNTAGMA

bioSyntagma is a precision medicine company dedicated to transforming how cancer is treated by providing deep data on the uniqueness of each persons cancer. The companys Molecular Fingerp...

Read More

map
  • 1878 E Watson Dr, Phoenix, Arizona, 85283, United States Headquarters: 1878 E Watson Dr, Phoenix, Arizona, 85283, United States
  • 2015 Date Founded: 2015
  • 1-10 Employees: 1-10
  • dollar-icon Revenue: $1 Million to $5 Million
  • tech-icon Active Tech Stack: See technologies

industries-icon Industry: Biotechnology

SIC SIC Code: 3841

checked-icon Does something look wrong? Fix it. | View contact records from BIOSYNTAGMA

bioSyntagma Org Chart and Mapping

Employees

Colleen Ziegler

Co Founder; Director of Operations

signout-image
You are signed out

Sign in to CIENCE GO Data to uncover contact details

crown-icon Free credits every month

Frequently Asked Questions Regarding BioSyntagma

Answer: bioSyntagma's headquarters are located at 1878 E Watson Dr, Phoenix, Arizona, 85283, United States

Answer: bioSyntagma's phone number is +18*********

Answer: bioSyntagma's official website is https://biosyntagma.com

Answer: bioSyntagma's revenue is $1 Million to $5 Million

Answer: bioSyntagma's SIC: 3841

Answer: bioSyntagma has 1-10 employees

Answer: bioSyntagma is in Biotechnology

Answer: bioSyntagma contact info: Phone number: +18********* Website: https://biosyntagma.com

Answer: bioSyntagma is a precision medicine company dedicated to transforming how cancer is treated by providing deep data on the uniqueness of each persons cancer. The companys Molecular FingerprintTM (mPrintTM) platform creates a comprehensive, multi-omic and spatial profile of tissue to get a complete and informed understanding of the patients cancer so they can be matched with relevant therapies and recommended course of actions that prevent acquired drug resistance. bioSyntagmas mPrintTM platform serves the needs of clinicians, academic researchers, and drug developers to advance the implementation of precision medicine for cancer treatment.

Answer:

Premium Sales Data for Prospecting

  • Sales data across over 200M records

  • Up-to-date records (less decayed data)

  • Accurate Email Lists (real-world tested)

  • Powerful search engine and intuitive interface

lock icon Get Full Access